Abstract:Developing a sensitive, low-cost and general sensing platform for the analysis of a DNA biomarker and its mutation is important for early cancer screening. In our work, the tumor suppressor gene-p53 DNA was chosen as the model DNA biomarker due to its vital role in preventing oncogene cancer-inhibiting activity through mediating cellular proliferation and apoptosis. Compared with tumor biopsy, the quantification of p53 DNA and its mutation in biofluids (such as urine) is more convenient due to its simple operation and non-invasiveness. Herein, a label-free amplified fluorescence assay has been developed for p53 DNA in urine samples through the KFP polymerase-driven double strand displacement reactions and a magnetic nanoprobe. First, the ssDNA probe (RP) was designed with antisense sequences for p53 DNA and the Nb.BbvCI endonuclease recognition site. In the presence of p53 DNA, the formed dsDNA between RP and p53 DNA served as an engaging primer to initiate the first strand displacement reaction (SDA) under the action of KFP DNA polymerase and Nb.BbvCI, generating abundant short ssDNA (primer). Subsequently, the resulting primers will initiate the downstream SDA through the primer-hairpin DNA (HPa) binding, opening up, and extension of HPb and HPc under the action of KFP DNA polymerase. In the process of this final DNA polymerization reaction, the primer hybridized on HPa is released and goes on to initiate another round, forming plenty of duplex Y-shaped DNA. With the integration of SYBR Green I (SG I) into these duplex DNA, the amplified label-free fluorescence detection platform for p53 DNA can be achieved. Moreover, a biotin modified nanoprobe (bio-CP) was used to capture the superfluous HP. By performing the separation function, the binding of superfluous HP and SG could be avoided and a low background can be acquired. Benefiting from the abundant SG intercalation sites of Y-shaped DNA and low background signals, this method showed excellent sensitivity with a detection limit of 0.012 nM, and the p53 DNA in urine samples was evaluated, offering a powerful tool for biomedical research and clinical diagnosis.

PCR-RFLP to detect codon 248 mutation in exon 7 of p53 tumor suppressor gene.

[Detection of P53 Mutation Using PCR-SSCP Silver Staining Method].

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

Application of immunohistochemistry-laser microdissection-PCR technique in detecting p53 gene mutation in paraffin sections of gastric cancer]

Application of Capillary Electrophoresis in Detecting Mutation of Hmlh1 Gene in Colorectal Cancer

Detection of P53 Gene Mutations in 14 Tumor Cell Lines

Analysis of p53 exon 4-8 gene mutations in human esophageal cancer tissue and nearby non-cancerous tissue

Detection of P53 Gene Mutations in Human Leukemia by Pcr-Sscp Analysis and Direct Nucleotide Sequencing

Detection of p53 gene mutation in exhaled breath condensate of patients with non-small cell lung cancer

Sequence Terminus Dependent PCR for Site-Specific Mutation and Modification Detection

Label-free amplified fluorescence detection of DNA biomarkers based on KFP polymerase-driven double strand displacement reactions and magnetic nanoprobes

Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population

Mutations of P53 Gene Exons 4-8 in Human Esophageal Cancer

Mutation-Selected Amplification droplet digital PCR: A new single nucleotide variant detection assay for TP53R249S mutant in tumor and plasma samples

A universal and sensitive gene mutation detection method based on CRISPR-Cas12a

Colorimetric and photothermal dual-modal analysis of a cancer-related gene based on G-quadruplex-hemin cascade signal amplification

On-chip Oligonucleotide Ligation Assay Using One-Dimensional Microfluidic Beads Array for the Detection of Low-Abundant DNA Point Mutations

Bioinformatic Identification of TP53 Gene Mutation Hotspots in Colorectal Cancer

RNA-templated single-base mutation detection based on T4 DNA ligase and reverse molecular beacon

Detection of P53 Gene Mutation in Plasma of Patients with Gastric Cancer

Mutational analysis of p53 gene in cervical cancer and useful polymorphic variants in exons 3 and 4